Egetis Therapeutics AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	215.8	351	303.3	127.7	144
Cash & Short-Term Investments	215.8	351	303.3	127.7	144
Cash Growth	-38.52%	15.73%	137.51%	-11.32%	-49.97%
Accounts Receivable	19.2	15.5	28.2	3.8	3.5
Other Receivables	8.7	8.1	8.4	6.7	3.3
Receivables	27.9	23.6	36.6	10.5	6.8
Inventory	2.3	1	0.7	0.6	0.7
Prepaid Expenses	7.5	4.1	4.4	8.2	1.3
Other Current Assets	0.1	0.4	0.9	0.4	0.1
Total Current Assets	253.6	380.1	345.9	147.4	152.9
Property, Plant & Equipment	9.7	2.6	4.4	2.7	4.3
Long-Term Investments	0.8	0.8	0.8	0.8	0.8
Other Intangible Assets	2.2	3.2	4.3	5.4	6.5
Long-Term Deferred Tax Assets	1.7	0.6	-	-	-
Long-Term Deferred Charges	371.1	404.8	404.8	404.8	404.8
Other Long-Term Assets	-	0.2	-	-	-
Total Assets	639.1	792.3	760.2	561.1	569.3
Accounts Payable	21.8	25.7	28.7	20	4.6
Accrued Expenses	176.7	131	47.2	12.7	5.3
Current Portion of Long-Term Debt	31.5	30.1	5.2	-	-
Current Portion of Leases	-	2.5	2.2	1.6	1.5
Current Income Taxes Payable	0.1	0.2	0.1	-	-
Other Current Liabilities	10.8	14.7	20.5	15.1	27.8
Total Current Liabilities	240.9	204.2	103.9	49.4	39.2
Long-Term Debt	45	84.1	103.4	-	-
Long-Term Leases	5.6	0.4	2.2	1.1	2.7
Long-Term Deferred Tax Liabilities	1.7	0.5	-	-	-
Other Long-Term Liabilities	7.2	10.2	5.1	4.4	0.4
Total Liabilities	300.4	299.4	214.6	54.9	42.3
Common Stock	22.3	20.4	15.4	11.3	8.7
Additional Paid-In Capital	2,228	2,058	1,780	1,428	1,263
Retained Earnings	-1,948	-1,610	-1,267	-939.6	-745.8
Comprehensive Income & Other	36.9	24.9	16.7	6.1	1.3
Shareholders' Equity	338.7	492.9	545.6	506.2	527
Total Liabilities & Equity	639.1	792.3	760.2	561.1	569.3
Total Debt	82.1	117.1	113	2.7	4.2
Net Cash (Debt)	133.7	233.9	190.3	125	139.8
Net Cash Growth	-42.84%	22.91%	52.24%	-10.59%	-50.63%
Net Cash Per Share	0.36	0.75	0.73	0.64	0.78
Filing Date Shares Outstanding	395.16	359.24	292.57	214.59	165.07
Total Common Shares Outstanding	395.16	359.24	292.57	214.59	165.07
Working Capital	12.7	175.9	242	98	113.7
Book Value Per Share	0.86	1.37	1.86	2.36	3.19
Tangible Book Value	336.5	489.7	541.3	500.8	520.5
Tangible Book Value Per Share	0.85	1.36	1.85	2.33	3.15
Machinery	-	0.1	0.3	0.2	0.3

Source: S&P Global Market Intelligence. Standard template. Financial Sources.